fda bans tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA says shortage of GLP-1

Glutathione infusion supports antioxidant defense and recovery

Stanton Chases Consumer Products and Services practice works with boards and leadership teams to find and develop the executives capable of leading through exactly this kind of structural demand disruption

The process is quick, secure and with regular use, you can experience a significant overall improvement in skin health

Pain can ease, inflammation can settle, and someone can return to movement without the underlying tissue having structurally repaired

In CDM, semaglutide users had significantly decreased risk of stroke (hazard ratio [HR], 0.54), myocardial infarction (HR 0.64), and their composite (HR 0.59) vs DPP-4is

If you have a family history of metabolic disease, elevated inflammation markers, or a long pattern of unsuccessful weight-loss attempts, you may still be an eligible candidate